Giorgio Minotti

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Acute Heart Failure

Cardiovascular Events

Top Venues

European heart journal

The Journal of pharmacology and experimental therapeutics

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Giorgio Minotti
Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock. Blood advances 8 (14) (2024)
Giorgio Minotti, Massimiliano Camilli
LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless Story. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Giorgio Minotti, Massimiliano Camilli
LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless Story. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Giorgio Minotti
Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock. Blood advances 8 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal 45 (14) (2024)
Giorgio Minotti, Massimiliano Camilli
LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless Story. The Journal of pharmacology and experimental therapeutics 388 (3) (2024)
Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltan V Varga
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European heart journal (2024)
Pierantonio Menna, Francesco Marchesi, Chiara Cattaneo, Anna Candoni, Mario Delia, Gianpaolo Nadali, Alessandra Vatteroni, Crescenza Pasciolla, Salvatore Perrone, Luisa Verga, Daniele Armiento, Maria Ilaria Del Principe, Nicola S Fracchiolla, Emanuela Salvatorelli, Santina Lupisella, Irene Terrenato, Alessandro Busca, Giorgio Minotti, Livio Pagano
Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study. Clinical and translational science (2023)
Giorgio Minotti
All Eyes on Me, Please: Ocular Palonosetron for the Cancer Patient with Nausea and Vomiting. The Journal of pharmacology and experimental therapeutics 386 (2) (2023)
Giorgio Minotti
A Special Section on Clinical Pharmacology-Editorial. The Journal of pharmacology and experimental therapeutics 386 (2) (2023)
Joerg Herrmann, Daniel J Lenihan, Saro H Armenian, Ana Barac, Anne H Blaes, Daniela Maria Cardinale, Joseph Carver, Susan F Dent, Bonnie Ky, Alexander Richard Lyon, Teresa López Fernández, Michael G Fradley, Sarju Ganatra, Curigliano Giuseppe, Joshua D Mitchell, Giorgio Minotti, Ninian N Lang, Jennifer E Liu, Tomas G Neilan, Anju Nohria, Rupal O'Quinn, Iskra Pusic, Charles Porter, Kerry L Reynolds, Kathryn J Ruddy, Paaladinesh Thavendiranathan, Peter Valent
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European heart journal 43 (4) (2022)